Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
about
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarineScreening and characterisation of antimicrobial properties of semisynthetic betulin derivativesEnhancing the divergent activities of betulinic acid via neoglycosylation.Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells.Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma.A small-molecule antagonist of virion assembly.Effect of overexpression of HOX genes on its invasive tendency in cerebral gliomaCrystal structure of betulinic acid methanol monosolvate.New ionic derivatives of betulinic acid as highly potent anti-cancer agents.A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo.The efficacy of betulinic acid in triple-negative breast cancer.Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents.Small mitochondria-targeting molecules as anti-cancer agents.Betulinic Acid and its Derivatives as Potential Antitumor Agents.Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy.Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.Production of anti-cancer triterpene (betulinic acid) from callus cultures of different Ocimum species and its elicitation.Betulinic acid induces Bax/Bak-independent cytochrome c release in human nasopharyngeal carcinoma cells.A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia.Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines.Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells.Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro.Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell lineBetulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway.Diosgenin-3-O-alpha-L-rhamnopyranosyl-(1 --> 4)-beta-D-glucopyranoside obtained as a new anticancer agent from Dioscorea futschauensis induces apoptosis on human colon carcinoma HCT-15 cells via mitochondria-controlled apoptotic pathway.Sensitization for anticancer drug-induced apoptosis by betulinic Acid.Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas.Betulinic Acid inhibits growth of cultured vascular smooth muscle cells in vitro by inducing g(1) arrest and apoptosis.Betulinic Acid for cancer treatment and prevention.Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2).Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations.Value of surveillance imaging in the management of medulloblastoma.Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors.Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).Natural products: a hope for glioblastoma patients.
P2860
Q21284162-AFDE6DB7-8552-4606-ACFE-6AC4E302107AQ28540869-C7D353AA-16BF-440E-A31C-C40C193C8E13Q33395056-86F92600-CA4E-4755-BE51-EE5B0C1C29EAQ33406013-96C02BD6-2C48-4051-9DFA-9858D9514EB3Q33879341-27AE6083-E168-454B-8EB8-F83D6BF7AC71Q34000246-6118E8FB-164A-4D2E-9FBA-49448CFB2C60Q34489215-DA59B472-B331-45DE-A4BE-F436DA894D82Q34513781-0EB3F0A2-6D3F-4CBF-9E4B-F824943C2AF6Q34638893-6778066B-A52D-491D-8D1B-B309743B67F4Q35742780-2C5DFF99-57EF-42EE-ABAE-5EE6647A93E9Q35921686-BE989C6F-9AB8-4DE6-9A37-57B792611E55Q36165932-411D2281-F6C1-4E7F-819C-11506603644FQ36368308-E646028C-A0B9-434F-8928-3701F56C53E3Q37354394-9D923376-8917-489A-A9A3-497B52EA8CB9Q37648872-F6E07CD7-EF30-4A56-B9F5-C52FBA7572C1Q38511656-32CC26F5-E284-4735-91D3-948C62D61221Q38590667-B23CEF17-CE93-45E2-865A-73609B111AECQ38624961-CEC9CC9A-3659-48A4-B432-D3A22628E44EQ38943486-745C7C92-008E-46F7-B461-B0515E53E5EEQ39114583-57FB45A5-A037-4C42-88F2-D2DDFF627819Q39360416-A1FA0721-9B53-44F3-B335-5957F09994B1Q39417215-CEE983F9-36FD-4B0A-9859-7C42B33EA64DQ39507613-93AB4FF0-9AC2-4B97-877D-469A8DCB2B91Q39704968-45E5BA49-4FFD-4E8E-B6DB-598D7A89E12CQ39722514-E6AD38D3-9759-452A-B56E-93317DAB80C6Q39767592-F97245FC-69A6-4E9E-9736-770538D4BE1AQ39788560-9BF8555A-C183-48CA-801E-88F6044D00D4Q39918480-0D2E4786-2467-41C5-9C37-C6E0AD649537Q40363935-3EB64DBB-E5F4-4975-AD15-3624D61722EEQ40580907-BC65FDB3-B2F7-4C13-BC8E-6DA6A63667A5Q41468780-325EC5C2-5ED1-43C8-997D-70A09FEB9608Q41845885-00661D0A-C93E-4299-90AA-1E8063A4A720Q42530252-E356D740-517A-4A19-A5B8-072761379A7DQ43159091-32267180-3691-4107-B00B-2E3C58473880Q47692134-8C9BA7AA-5A0D-45BD-B6BB-1353990180D9Q50335864-4CA2E82F-BB17-47F6-815F-ED6652F02267Q52936968-A9BFA7FF-C51B-44D5-8130-032F0A108D26Q54027478-B0560A07-6E8E-4A44-9DFC-7AB624D71A39Q55343131-277F26B6-BE87-407F-953E-02AFEBBA5D2DQ55445418-6683ABBB-031D-4D72-91EB-6EF012376982
P2860
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@en
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@nl
type
label
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@en
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@nl
prefLabel
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@en
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@nl
P2860
P50
P1476
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
@en
P2093
H H Steiner
P2860
P304
P356
10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1
P577
1999-07-01T00:00:00Z